For customers outside of Japan
Established through the 2010 acquisition of major SMO Total Trial Management Consulting Co., Ltd. by EPS, EPS Taiwan provides CRO and SMO services and boasts the capacity to accommodate clinical studies in situations where gathering cases is severely challenging such as a large volume of cases must be gathered in a short period of time. EPS Taiwan conducts studies across phases I-IV, including post-marketing sales and support, in-sourcing and site management services.
Health Expenditure per Capita
(2018, US$)
$1632
Source: Financing Global Health Database 2018
Population(2019)
24
million people
Source: The World Bank
Burden of Disease DALYs Causes % of Total DALYs
(2017, all ages/both sexes)
Diabetes Mellitus (5.55%)
Chronic obstractive pulmonary
disease (5.32%)
Stroke (5.2%)
Source: Institute Health Matrics and Evaluation GBD
NDA Approval Time
12
months
Entering the Chinese market has just become easier as cross-strait cooperation bears fruit
Taiwan's strategic focus on biotechnology, its GCP-compliant professionals, global outlook and widely respected FDA, are some of the reasons why the country has long been a vibrant and sought-after location for contract research ...
Merged research promotion body NRBP creates streamlined vehicle for encouraging research
The National Research Program for Biopharmaceuticals (NRBP) was formed in 2011 from the merger of two national research promotional bodies in biotechnology and pharmaceuticals, and genomic medicine. The NRBP objective is to create a ...
Contact Us
Monitoring
Share this page